Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In The News – Tracking The Latest Industry Personnel Moves

Executive Summary

New top leadership at BrainStorm Cell Therapeutics, Rexahn Pharmaceuticals; BioInvent seeking new CEO; Clancy steps down as AHRQ director; co-founders from Anacor Pharmaceuticals and InVivo Therapeutics recognized by White House. More personnel announcements in this month’s column.

You may also be interested in...

Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties

Former J&J and Sandoz executive Leona Brenner-Gati to become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.

AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later

AstraZeneca's new CEO Pascal Soriot signaled significant change is afoot for the troubled drug maker by eliminating the jobs of R&D President Martin Mackay and Exec VP-Global Commercial Tony Zook.

Clinton Veteran DeParle Brings Medicare, Budget Pragmatism To White House

Sebelius-DeParle team fuses elected government manager with insurance knowledge with Washington health professional with hands-on budget and Medicare/Medicaid experience.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts